Figure 4.

PTERT mutation leads to pleasant prognosis outcomes in IDH-mutant glioma patients (fixed-effect models). IDH: Iso-citrate dehydrogenase

PTERT mutation leads to pleasant prognosis outcomes in IDH-mutant glioma patients (fixed-effect models). IDH: Iso-citrate dehydrogenase